
CAS 865608-11-3
:CMPD101
Description:
CMPD101, with the CAS number 865608-11-3, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized by its specific molecular structure, which includes functional groups that contribute to its biological activity. CMPD101 has been studied for its role as a selective inhibitor, often targeting specific enzymes or receptors within biological systems. Its solubility, stability, and reactivity are important factors that influence its efficacy and safety profile in pharmacological contexts. Additionally, CMPD101 may exhibit unique properties such as lipophilicity or hydrophilicity, which affect its absorption, distribution, metabolism, and excretion (ADME) characteristics. Research into CMPD101 continues to explore its mechanisms of action, potential side effects, and therapeutic windows, making it a compound of interest in drug development and biomedical research. As with any chemical substance, proper handling and safety measures are essential when working with CMPD101 in laboratory settings.
Formula:C24H21F3N6O
Synonyms:- 3-[[[4-Methyl-5-(4-pyridinyl)-4H-1,2,4-triazol-3-yl]methyl]amino]-N-[[2-(trifluoromethyl)phenyl]methyl]benzamide
- Takeda101
- CMPD101
- Benzamide, 3-[[[4-methyl-5-(4-pyridinyl)-4H-1,2,4-triazol-3-yl]methyl]amino]-N-[[2-(trifluoromethyl)phenyl]methyl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
CMPD101
CAS:<p>CMPD101 is a membrane-permeable small-molecule inhibitor of GRK2/3 (IC50: 18 nM and 5.4 nM).</p>Formula:C24H21F3N6OPurity:99.01% - 99.04%Color and Shape:SolidMolecular weight:466.46CMPD101
CAS:Controlled Product<p>Applications CMPD101 is a potent and selective GRK2/3 inhibitor.<br>References Lowe, J.D., et al.: Mol. Pharmacol., 88, 347 (2015); Ikeda, S., et al.: PCT Int. Appl. WO 2007034846 A1 20070329. Mar 29, 2007<br></p>Formula:C24H21F3N6OColor and Shape:NeatMolecular weight:466.46CMPD101
CAS:<p>CMPD101 is a dopamine receptor agonist that has been shown to have antimicrobial effects. It has a pyrazole ring that binds to the cation channel, which causes an increase in the permeability of the membrane to potassium ions and leads to cardiac arrest. CMPD101 is also able to bind to other receptors such as oxytocin, CB2, and d2 dopamine receptors. This compound has been shown in vivo treatment for metabolic disorders and autoimmune diseases as well as having pharmacokinetic properties.</p>Formula:C24H21F3N6OPurity:Min. 95%Molecular weight:466.46 g/mol




